Status:
COMPLETED
A Web-Based Tool to Improve Breast Cancer Survivorship
Lead Sponsor:
Northwestern University
Conditions:
Breast Cancer
Hormone Dependent Neoplasms
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine the efficacy of a psychosocial eHealth intervention on the proposed primary outcomes, hormone therapy adherence and health related quality of life (HRQoL), in b...
Detailed Description
Breast cancer is the most commonly diagnosed cancer among women in the U.S. Approximately 75% to 80% of breast cancer survivors are prescribed HT (hormone therapy) medication for 5 to 10 years followi...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- English-speaking (6th grade reading level) as required to complete assessments
- medical chart confirmed diagnosis of hormone-receptor positive non-metastatic breast cancer
- Stages I-IIIa
- completion of any combination of surgical, radiation, and chemotherapy treatment
- willingness to be randomized into study
- have initiated HT within the past 6 months as data in literature indicates that the overwhelming majority of women who initiated HT are still adherent within the first 4 months
- first-time diagnosis of breast cancer
- access to a computer or tablet with Internet capabilities
Exclusion
- Visual, hearing, voice, or motor impairment that would prevent completion of study procedures
- diagnosis of an unmanaged psychotic or psychiatric disorder (e.g., clinical depression, anxiety, or PTSD), bipolar disorder, dissociative disorder, or other diagnosis for which participation in this trial is either inappropriate or dangerous - this includes patients who have life-threatening illness (e.g., end-stage kidney disease) or diagnosis of a chronic disease that is associated with a major functional impairment (e.g., chronic severe pain, fibromyalgia)
- Alzheimer's, dementia or history of stroke
Key Trial Info
Start Date :
May 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT03849573
Start Date
May 29 2019
End Date
May 1 2022
Last Update
July 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611